Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Researchers present a novel method to predict the risk of rejection after heart transplant

April 17, 2014

Neuregulin-1 expression correlates with sensitivity to GDC-0032 PI3K inhibitor

April 17, 2014

Interstitial deletion of 8p23.1 indicates a new causative gene for heterotaxy

April 17, 2014

Sigma-Tau describes novel HSP 90 inhibitor

April 17, 2014

Phase I results for MRX-34, a first-in-class liposome formulated miR-34 mimic

April 17, 2014

Novel putative antisense mitochondrial RNA-based therapy for renal cell carcinoma

April 16, 2014

TT-genotype of IL-23R has protective effect in lung transplant recipients

April 16, 2014

Ace2 gene therapy reduces liver fibrosis in mice

April 16, 2014

Germline PIGA mutations linked to new genetic syndrome

April 16, 2014

AQP-5 expression and polymorphisms predict early breast cancer survival

April 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...